Global Antithrombin Market - Market Size, Share & Industry Trends, Growth Analysis Report By Application Type, By Source and Forecast 2017 - 2025


DescriptionTable of ContentList of TablesList of Figures
Introduction
Antithrombin Market was valued at USD XX Billion in 2019 and is projected to reach USD XX billion by 2025, at a CAGR of XX% from 2020-2025. Antithrombin is a type of protein found in human blood which act as a natural blood thinner and thus, plays an important role in prevention of blood clotting. It is extensively used during the surgeries for the patient with low antithrombin levels. As per the research studies, by 2030 one person in every six people will live 65 and hardly above, which clearly mentions the unhealthy lifestyle and short life spam of people in the upcoming decades. The risk for cardiovascular diseases will increase and so the antithrombin market will have the growth. 
The global antithrombin market is primarily driven by the widespread use of antithrombin for the treatment of several medical conditions such hereditary deficiency of antithrombin deficiency, extracorporeal membrane oxygenation, disseminated intravascular coagulation, and sepsis. The increasing use of antithrombin twined with heparin is likely to open extremely great opportunities for this market. 
“Therapeutics is the most attractive application type”
In 2019, the therapeutics application segment accounted a market share of 95.7%. By source goat milk
 
Geographical Overview
Asia-Pacific is more likely to be the fastest growing region in the market during the forecasted period, which accounted for USD 190 million in 2019. Also Europe holds a high potential for the growth of this market. This is attributed due to the growing familiarity of the antithrombin III deficiency amongst the population. Key factors such as changing eating habits, fast lifestyle and increasing risk of the diseases and also the awareness about the same driven the rise in the growth of the antithrombin market. North America, and the Latin America are also major regions in the global antithrombin market.
Segmental Overview
Antithrombin Market is segmented as per below specifications -  
By Application: 
•	Therapeutics
•	Research
•	Diagnostics
By Source: 
•	Human
•	Goat milk
•	Others
By Dosage form:
•	Lyophilized
•	Liquid

Competitor Analysis
Antithrombin Market has presence of some of the key major players across globe which includes
•	Grifols
•	LFB USA
•	Shire Plc.
•	CSL Ltd.
•	Kedrion S.P.A.
•	Octapharma AG
•	Lee Biosolutions
•	Scripps Laboratories
•	Diapharma Group Inc. 
These key players are concentratingits efforts on the continuous product improvement with innovative initiatives to have an edge over other competitors. Further, to garner maximum market share,companies are adoptingmerger/ acquisition/ partnership and maintaining strong distribution networks strategies.  
By Geographical Locations: 
•	North America
o	U.S.
o	Canada
•	Europe
o	U.K.
o	France
o	Italy
o	Germany
o	Spain
o	Russia & CIS
o	Rest of Europe
•	Asia-Pacific
o	China 
o	India
o	Japan
o	South Korea
o	ASEAN
o	Rest of Asia Pacific 
•	Latin America
o	Brazil
o	Argentina
o	Rest of LATAM
•	Middle East & Africa
o	UAE
o	South Africa
o	Rest of MEA


Highlights of the report
What is Antithrombin Market?
Who all are key market players in the industry?
How the Parent Industry is growing?
Where are the key opportunities for new market entrant?
A comprehensive analysis, which covers key growth factors across the value chain
Recent developments in market
Granular Market Segmentation 
Market size projection based on Historical & current market trends 
Market share analysis and key strategies adopted by leadingPlayers
Production Cost & Sensitivity Analysis
Country Level Market Analysis of Top 16 countries
Data Driven Decision Recommendations